Brain Stimulation for Patellofemoral Pain Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This study sought to investigate whether modulation of cortical excitability of the gluteal musculature, via tDCS paired with exercise, will reduce the amount the knee caves in during functional tasks in individuals with PFP. The objective is the explore if having tDCS target the area of the brain controlling hip muscles, when paired with exercise, will be more effective in reducing the amount the knee caves in for individuals with PFP versus those who receive exercise alone as their treatment. The aim is to contribute our findings to the growing knowledge in this area in order to help establish the possibility, and feasibility, of its use in clinical settings to strengthen traditional treatments for this patient population.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking anti-seizure medication.
Is transcranial direct current stimulation (tDCS) safe for humans?
Transcranial direct current stimulation (tDCS) is generally considered safe for humans, with mild and temporary side effects like itching, tingling, and headaches. Studies have shown no serious adverse effects when used at standard levels (up to 4 milliamperes for 40 minutes) across a wide range of people, including potentially vulnerable groups.12345
How does the treatment transcranial direct current stimulation (tDCS) differ from other treatments for patellofemoral pain syndrome?
What data supports the effectiveness of the treatment Transcranial Direct Current Stimulation (tDCS) for Patellofemoral Pain Syndrome?
Research shows that using transcranial direct current stimulation (tDCS) can increase muscle strength and reduce pain in women with patellofemoral pain. Additionally, tDCS has been effective in reducing pain in other conditions like knee osteoarthritis, suggesting it may help with patellofemoral pain as well.89101112
Who Is on the Research Team?
Kai Yu Ho, PhD
Principal Investigator
UNLV
Are You a Good Fit for This Trial?
This trial is for individuals with Patellofemoral Pain Syndrome (PFP), which often causes knee pain and discomfort. Participants should be experiencing knee caving in during physical activities. The study is not suitable for those who cannot safely receive transcranial direct current stimulation or exercise therapy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive transcranial direct current stimulation (tDCS) paired with exercise to modulate cortical excitability and improve functional movements
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Transcranial Direct Current Stimulator
Transcranial Direct Current Stimulator is already approved in United States, European Union, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Nevada, Las Vegas
Lead Sponsor